Kalorama Information is the authoritative market research source for the diagnostics industry. Find essential insights, market shares, sales segmentation and projections for in vitro diagnostics (IVD) and medical imaging markets. Kalorama’s reports, including The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 13th edition, analyze the global in vitro diagnostics market, now worth approximately $83.3 billion. Our diagnostics market research covers trends in health care service delivery, including the rapidly advancing diagnostic laboratory technology industry. Discover emerging diagnostics market niches in our updated reports that present the trends, technologies, customer needs, and major suppliers currently shaping the diagnostics industry.
Molecular Assays
Point-of-Care
Immunoassays
Infectious Disease
Clinical Chemistry
Oncology/Hematology
Lab Testing Services
Medical Imaging
- Sort by Popularity (sales)
- Display 15 Products per page
Published: July 29, 2021 | Price: $8,250.00 – $16,500.00
Kalorama Information's latest edition of our in vitro diagnostic market report is now available. This represents the fourteenth time in two decades our analysts have fully assessed the in vitro diagnostic market from scratch and re-report numbers. Last year, the COVID-19 pandemic highlighted how important testing is in a way that could not be imagined This year, COVID-19 is to some degree a routine test category in respiratory and infectious disease testing, themselves high-growth segments. Now the question will be...Published: July 31, 2020 | Price: $8,250.00 – $16,500.00
Download Brochure What is the Size of the IVD Market in 2020? In its latest report Kalorama Information estimates the market for in vitro diagnostic products, including instruments, reagents and associated supplies to be $83.3 billion dollars. This is a substantial increase over our 2019 estimates, with 9 billion dollars of revenue originating from molecular and antibody COVD-19 testing responsible for most of the growth. Other infectious diseases (particularly respiratory pathogens), advanced cancer IVDs and increasing used of critical care...Published: March 20, 2023 | Price: $7,000.00 – $14,000.00
For Two Decades, One Volume Has Offered Complete Coverage of The IVD Industry Now with a March 2023 Addendum The 15th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests is a must have for anyone interested or involved in the IVD industry. Having a guide for the state of IVD and its future is a vital part of making well-informed decisions. The 15th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates,...Published: August 2, 2019 | Price: $8,000.00 – $16,000.00
Now in its 12th edition, this Kalorama Information report, The Worldwide Market for In Vitro Diagnostic (IVD) Tests, is the most essential report on the IVD industry. The 2,000-page report provides in vitro diagnostics market size estimates and projections for the entirety of the in vitro diagnostics testing market. 2000-Page Report Based on Vendor Reporting, Interviews, Vendor Activities Authored by Veteran IVD Analysts with Industry Knowledge 12 Detailed Market Chapters with 2019 Market Estimate Where is IVD Heading? – Market Segment...Published: June 17, 2021 | Price: $5,000.00 – $10,000.00
Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in the evaluation of suitability of various cancer treatment options, pharmacokinetics or patient metabolism of drugs for HIV, psychiatric conditions or blood thinners; cancer prognosis and...Published: February 23, 2021 | Price: $4,000.00 – $8,000.00
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2020-2025 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business...Published: April 13, 2023 | Price: $6,000.00 – $12,000.00
The point-of-care diagnostics market has long been the opportunity market within IVD. Kalorama publishes a full-scope market research study annually on point of care (POC) devices that can test near the patient for maximum benefit to healthcare encounters. While tests run on lab-based analyzers, remain the bedrock of IVD revenues, point of care has always been seen as the growth area. There are more companies in the point of care market, and it is a top segment of investment. Now...Published: February 7, 2023 | Price: $5,000.00 – $10,000.00
This report is an essential tool for understanding the size and growth opportunity in molecular POC. Molecular point of care (mPOC) has gone from novel trend to significant contributor to the market. The instruments sold by Abbott, BioMérieux, Cepheid and increasingly, a host of other companies, are a significant contributor to the IVD POC market. Knowing these markets is essential to knowing the opportunity in point of care testing and microbiology IVD. Since 2013, Kalorama has been producing a dedicated...Published: April 13, 2021 | Price: $5,000.00 – $10,000.00
By the middle of the decade, point of care testing is expected to reach 45 billion dollars annually. This should not be surprising. Globally, millions of dollars are spent annually on POC diagnostic testing, both professional testing and self-testing. In 2020, sales of POC testing reached $29,316 million. COVID-19 was a significant game changer in 2020. The number of new tests for POC COVID-19 was stunning. Updated for COVID-19 Impacts In some segments, COVID-19 caused a contraction of the segment...Published: January 22, 2021 | Price: $4,000.00 – $8,000.00
This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular point of care or mPOC systems are designed to be faster than lab-based tests while more accurate than existing point of care systems. Development of...Published: November 2, 2020 | Price: $4,000.00 – $8,000.00
COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: COVID-19 has seen the molecular in...Published: September 24, 2020 | Price: $5,500.00 – $11,000.00
Laboratory developed tests (LDTs) are not a new or recent phenomenon but due to the incredible need for testing of SARS-CoV-2, there has been a flood of new tests and the regulatory guidance has changed dramatically. Historically, these tests were called “home-brew tests” or “in-house tests.” Also, historically, these tests were low-volume, simple and well characterized tests for low-risk diagnostic applications. Today, high-risk, complex tests have been developed as LDTs, and are being used to provide clinical results to physicians...Published: March 17, 2020 | Price: $5,500.00 – $11,000.00
This report represents the 7th edition of a fast-growing and competitive category of the in vitro diagnostic market. Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years as demand for accurate and fast testing has grown both inside and outside the hospital setting. The increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to...Published: February 12, 2020 | Price: $5,500.00 – $11,000.00
The potential of molecular diagnostic tools was initially recognized by onco-hematologists during the 1980s based on the observation that specific chromosomal translocations may significantly aid the diagnosis of various types of leukemia and lymphoma. Later, the emergence of user-friendly molecular methods such as PCR has opened up practical applications that helped multiple approaches for cancer diagnosis and treatments. DNA sequencing is increasingly employed in cancer molecular diagnostics. PCR is the initial step used in isolating and amplifying specific regions of...Published: September 2, 2022 | Price: $0.00 – $12,000.00
The global in vitro diagnostic (IVD) industry incorporates a sizable contract manufacturing segment that supplies a full range of reagents and test kits, instruments and systems, and testing accessories. Already a multi-billion dollar market, this segment is well positioned to generate favorable long-term growth, as detailed in this report, The Market for Contract Manufacturing in IVD. Most leading worldwide of producers of proprietary IVD systems will increase their reliance on outside contractors as a cost-effective means to: expand existing product...